Possible [qlco]    
Mechanical [ftcn]    
Action [ftcn]    
calcium antagonist [phsu]    
Triglyceride Metabolism [moft]    
Evaluable [ftcn]    
Effect [qlco]    
Type [qlco]    
calcium antagonist [phsu]    
plasma lipid [lbpr]    
Level [qlco]    
Obese [dsyn]    
Rats, Zucker [mamm]    
Rat [mamm]    
TREAT [topp]    
Oral [spco]    
<3 [qnco]    
mg/kg/day [qnco]    
7 days [tmco]    
Plasma [bdsu]    
CTG [medd]    
TG [lbpr]    
Rich [qlco]    
Level [qlco]    
Dose [qnco]    
Decrease [qnco]    
Increase [qnco]    
Total Cholesterol [lbpr]    
Level [qlco]    
Not [ftcn]    
Change [ftcn]    
To [qlco]    
Mechanical [ftcn]    
Decrease [qlco]    
Plasma [bdsu]    
TG [lbpr]    
Level [qlco]    
examinations [fndg]    
Effect [qlco]    
synthesis [biof]    
SECRET [biof]    
TG [lbpr]    
Rich [qlco]    
Human Cell Line [cell]    
Intestinal [bpoc]    
Associate [menp]    
degradation [ftcn]    
human cell [lbtr]    
Hepatoblastoma [neop]    
Caco-2 Cells [cell]    
Membrane [tisu]    
Filter [mnob]    
AD [ftcn]    
Apical [spco]    
Side [spco]    
>5 [qnco]    
inhibited [qlco]    
SECRET [biof]    
TG [lbpr]    
suppress [ftcn]    
SECRET [biof]    
HepG2 Cell [cell]    
Increase [qnco]    
Cellular [cell]    
Uptake [phsf]    
Result [ftcn]    
Suggest [idcn]    
Decrease [qnco]    
Plasma [bdsu]    
TG [lbpr]    
Level [qlco]    
inhibited [menp]    
Intestinal secretion [bdsu]    
Enhance [topp]    
Hepatic [blor]    
Uptake [phsf]    
treatment [ftcn]    
Hypertension [fndg]    
patient [podg]    
Hypertriglyceridaemia [fndg]    
Risk factor [qnco]    
coronary heart disease [dsyn]    
